PCYT2 and Hepatic steatosis: As demonstrated via several lines of evidence obtained from cell culture and animal models, Pcyt2 plays a pivotal role in the execution of the processes deregulation of which could lead to the development of obesity, insulin resistance, liver steatosis and dyslipidemia.